Literature DB >> 33118921

Pseudoxanthomonas winnipegensis sp. nov., derived from human clinical materials and recovered from cystic fibrosis and other patient types in Canada, and emendation of Pseudoxanthomonas spadix Young et al. 2007.

Kathryn A Bernard1,2, Alicia Vachon1,2, Ana Luisa Pacheco2, Tamara Burdz2, Deborah Wiebe2, Daniel R Beniac2, Shannon L Hiebert2, Tim Booth1,2, Dena Annie Doyle3, Paul Lawson3, Anne-Marie Bernier4.   

Abstract

Twelve isolates recovered from 10 cystic fibrosis/other patient types and a variety of clinical sources, were referred to Canada's National Microbiology Laboratory over 7 years. These were assignable to the genus Pseudoxanthomonas but were unidentifiable to species level. Patients included five males and five females from two geographically separated provinces, ranging in age from 2 months to 84 years. In contrast, most Pseudoxanthomonas species described to date have been derived from water, plants or contaminated soils. By 16S rRNA gene sequencing, the patient strains had ≥99.4 % similarity to each other but only 97.73-98.29 % to their closest relatives, Pseudoxanthomonas spadix or Pseudoxanthomonas helianthi. Bacteria were studied by whole genome sequencing using average nucleotide identity by Blastn, digital DNA-DNA hybridization, average amino acid identity, core genome and single nucleotide variant analyses, MALDI-TOF, biochemical and cellular fatty acid analyses, and by antimicrobial susceptibility testing. Bacterial structures were assessed using scanning and transmission electron microscopy. Strains were strict aerobes, yellowish-pigmented, oxidative, non-motile, Gram-stain-negative bacilli and generally unable to reduce nitrate. Strains were susceptible to most of the antibiotics tested; some resistance was observed towards carbapenems, several cephems and uniformly to nitrofurantoin. The single taxon group observed by 16S rRNA gene sequencing was supported by whole genome sequencing; genomes ranged in size from 4.36 to 4.73 Mb and had an average G+C content of 69.12 mol%. Based on this study we propose the name Pseudoxanthomonas winnipegensis sp. nov. for this cluster. Pseudoxanthomonas spadix DSM 18855T, acquired for this study, was found to be non-motile phenotypically and by electron microscopy; we therefore propose the emendation of Pseudoxanthomonas spadix Young et al. 2007 to document that observation.

Entities:  

Keywords:  clinical isolates; cystic fibrosis patients; emendation of Pseudoxanthomonas spadix; winnipegensis

Year:  2020        PMID: 33118921     DOI: 10.1099/ijsem.0.004533

Source DB:  PubMed          Journal:  Int J Syst Evol Microbiol        ISSN: 1466-5026            Impact factor:   2.747


  2 in total

1.  Notification List of Bacterial Strains Made Available by the United Kingdom National Collection of Type Cultures in 2021.

Authors:  Jake David Turnbull; Jo Dicks; Sunita Gurung; Hannah McGregor; Sarah Alexander
Journal:  Microbiol Resour Announc       Date:  2022-07-26

2.  Isolation and Characterization of the Lytic Pseudoxanthomonas kaohsiungensi Phage PW916.

Authors:  Chang Wen; Chaofan Ai; Shiyun Lu; Qiue Yang; Hanpeng Liao; Shungui Zhou
Journal:  Viruses       Date:  2022-08-02       Impact factor: 5.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.